Concepedia

Phase <scp>II</scp> multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage <scp>IB</scp> – <scp>IVA</scp> mycosis fungoides/Sézary syndrome

Fiona Child, Pablo L. Ortiz‐Romero, Rute Alvarez, M. Bagot, Rudolf Stadler, Michael Weichenthal, Rita Valério Alves, Pietro Quaglino, M. Beylot‐Barry, Richard Cowan,

British Journal of Dermatology · 2016 · 63 citations · 22 references

DOIFull text

Open access

Abstract

Quisinostat 12 mg three times weekly is active in the treatment of patients with relapsed or refractory CTCL, with an acceptable safety profile. Combination therapy with other drugs active in CTCL may be appropriate.

References

22

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Elise A. Olsen, Eric C. Vonderheid, Nicola Pimpinelli et al. · Blood · 2007 · 1.4K citations

FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Martin H. Cohen et al. · The Oncologist · 2007 · 1.3K citations · Full text

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Madeleine Duvic, Rakshandra Talpur, Xiao Ni et al. · Blood · 2006 · 1.1K citations · Full text

Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

Elise A. Olsen, Youn H. Kim, Timothy M. Kuzel et al. · Journal of Clinical Oncology · 2007 · 1K citations

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

B.H. Thiers · Yearbook of Dermatology and Dermatologic Surgery · 2008 · 978 citations

, , +9